Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2014
08/14/2014US20140227797 Diagnostic use of prosomatostatin
08/14/2014US20140227786 Retroviral Vector Particles and Methods for their Generation and Use
08/14/2014US20140227766 Purification of biological products by constrained cohydration chromatography
08/14/2014US20140227723 Engineered microbe-targeting molecules and uses thereof
08/14/2014US20140227294 Prolactin receptor binding proteins and uses thereof
08/14/2014US20140227293 Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
08/14/2014US20140227292 Anti-MCAM Antibodies And Associated Methods Of Use
08/14/2014US20140227291 Amyloid-beta binding proteins
08/14/2014US20140227290 Method for increasing n-glycosylation site occupancy on therapeutic glycoproteins produced in pichia pastoris
08/14/2014US20140227289 Compounds and methods for treating insulin resistance syndrome
08/14/2014US20140227287 Novel anti-human ngf antibody
08/14/2014US20140227286 Annexin A2 as Immunological Target
08/14/2014US20140227285 Anti-pseudomonas psl binding molecules and uses thereof
08/14/2014US20140227284 Synthetic lethality and the treatment of cancer
08/14/2014US20140227283 Anti-axl antibodies and uses thereof
08/14/2014US20140227281 Methods of Treating Herpesvirus Infections
08/14/2014US20140227280 Protein complex comprising mcm8 and mcm9 proteins and their use
08/14/2014US20140227279 Methods and compositions for the treatment of autoimmune and inflammatory diseases
08/14/2014US20140227278 Antibodies to human signal peptide-containing proteins
08/14/2014US20140227277 Combination therapy with an anti-CD19 antibody and a purine analog
08/14/2014US20140227276 Gpr177 as target and marker in tumors
08/14/2014US20140227275 Methods of treating and diagnosing pancreatitis
08/14/2014US20140227274 Prevention and Treatment of Amyloidogenic Disease
08/14/2014US20140227273 Multi-specific binding molecules targeting aberrant cells
08/14/2014US20140227272 Anti-Leukocyte Adhesion for the Mitigation of Potential Adverse Events caused by CD3-Specific Binding Domains
08/14/2014US20140227271 Somatic mutations in atrx in brain cancer
08/14/2014US20140227270 Bispecific anti-cxcr7 immunoglobulin single variable domains
08/14/2014US20140227269 Therapeutic nuclease compositions and methods
08/14/2014US20140227268 Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (dc-asgpr)
08/14/2014US20140227267 Bovine fusion antibodies
08/14/2014US20140227266 NOGO Receptor Antagonists
08/14/2014US20140227265 Method of treating or ameliorating metabolic disorders using clec-2
08/14/2014US20140227264 Drug fusions and conjugates with extended half life
08/14/2014US20140227259 Modified proteins and peptides
08/14/2014US20140227258 Humanized anti-cmet antagonists
08/14/2014US20140227257 Monoclonal Antibodies that Neutralize Anthrax Protective Antigen (PA) Toxin
08/14/2014US20140227256 Predictive biomarker for cancer treatment with ADCC-enhanced antibodies
08/14/2014US20140227254 Antagonists of bmp9, bmp10, alk1 and other alk1 ligands, and uses thereof
08/14/2014US20140227253 Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
08/14/2014US20140227252 Methods and Monitoring of Treatment with a DLL4 Antagonist
08/14/2014US20140227251 Methods for identifying antibodies with reduced immunogenicity
08/14/2014US20140227250 Stable formulations of antibodies to tslp
08/14/2014US20140227226 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
08/14/2014US20140227178 Humanized Anti-HLA-DR Antibodies
08/14/2014US20140227172 Diagnosis and treatment of prostate cancer
08/13/2014EP2765192A1 Antigen-binding molecule for promoting clearance from plasma of antigen comprising saccharide chain receptor-binding domain
08/13/2014EP2765141A1 Compositions comprising agents that inhibit neuroplilin and tolloid like 2
08/13/2014EP2765137A1 Induction of cross-reactive cellular response against rhinovirus antigens
08/13/2014EP2764026A2 Antibody specifically binding to epitope in sema domain of c-met
08/13/2014EP2764025A1 Ige anti -hmw-maa antibody
08/13/2014EP2764024A1 Anti c-met antibody and uses thereof
08/13/2014EP2764023A2 Anti-human sema4a antibodies useful to treat disease
08/13/2014EP2764022A1 Phosphospecific antibodies recognising tau
08/13/2014EP2764021A2 Generation of antibodies to an epitope of interest that contains a phosphomimetic amino acid
08/13/2014EP2764020A1 Process for antibody g1 glycoform production
08/13/2014EP2650367A9 Human monoclonal antibody
08/13/2014CN103987730A 特异性结合c-met的sema域中表位的抗体 Specifically binds to c-met sema domain epitope
08/13/2014CN103987729A 癌胚抗原相关细胞粘附分子(ceacam)的抗体 Carcinoembryonic antigen-related cell adhesion molecule (ceacam) antibody
08/13/2014CN103987405A 抗pd-l1抗体及其用途 Antibodies and anti-pd-l1 use
08/13/2014CN103983778A 一种检测受实验者体液体外促进疾病相关蛋白聚合能力的方法 A detection method experimenter humoral disease-related protein aggregation in vitro to promote the ability of affected
08/13/2014CN103981191A 一种抗cd20单链抗体的植物种子表达系统 An anti-cd20 single-chain antibody expression systems plant seeds
08/13/2014CN103981190A 结合egfr的抗原结合分子，编码它的载体，及其应用 Egfr binding antigen-binding molecules, vectors encoding it, and its application
08/13/2014CN103981150A 抗人b7-h4单克隆抗体及其制备和应用 B7-h4 anti-human monoclonal antibodies and their preparation and application
08/13/2014CN103980364A 一种全人源抗her2单克隆抗体及其制备方法与应用 One kind of fully human monoclonal antibodies anti-her2 its preparation method and application
08/13/2014CN103980363A 人巨细胞病毒中和抗体及其应用 HCMV neutralizing antibodies and their application
08/13/2014CN103980362A 抗体工程改造方法 Antibodies engineered methods
08/13/2014CN103980361A 抗体 Antibody
08/13/2014CN103254312B 一种鼠源单克隆抗体及其制备方法和用途 A murine monoclonal antibodies and their preparation and use
08/13/2014CN102998461B 乳及蛋白饮品中小麦球蛋白快速定性检测试剂及制备方法 Milk and protein drinks wheat globulin rapid qualitative detection reagent and preparation method
08/13/2014CN102942519B 烯啶虫胺半抗原、人工抗原和抗体及其制备方法与应用 Nitenpyram hapten, artificial antigen and antibody and its preparation method and application
08/13/2014CN102702322B 一种h1亚型特异性保守表位、抗体及其应用 One kind h1 subtype-specific conserved epitope, the antibody and its application
08/13/2014CN102636644B 检测禽白血病群特异性抗原的双抗体夹心elisa试剂盒 Detection of avian leukemia group specific antigens double antibody sandwich elisa kit
08/13/2014CN102633881B 针对her-3的抗体及其用途 For her-3 antibodies and uses thereof
08/13/2014CN102464718B 人源化之单克隆抗体、其氨基酸序列与核苷酸序列与其用途 A humanized monoclonal antibody, the amino acid sequence of the nucleotide sequence and its use
08/13/2014CN102438652B 抗体制剂 Antibody preparations
08/13/2014CN102317316B 人抗α突触核蛋白自身抗体 Human anti-α-synuclein antibodies
08/13/2014CN102186884B 成纤维细胞生长因子受体-3（fgfr-3）抑制物 Fibroblast growth factor receptor -3 (fgfr-3) inhibitor
08/13/2014CN102108355B 恶性疟原虫的多表位人工抗原及其用途 Plasmodium falciparum and its multi-purpose artificial antigen epitope
08/13/2014CN101928344B 抗cd20的人单克隆抗体 The human monoclonal antibody anti-cd20
08/13/2014CN101796073B 针对cxcr3的人源化抗体 For the humanized antibody cxcr3
08/12/2014US8802920 Acellular tissue matrices made from α-1,3-galactose-deficient tissue
08/12/2014US8802837 Nucleic acids molecule encoding the polypeptide for treating virus-induced cancer
08/12/2014US8802827 AX1 PCSK9 antagonists
08/12/2014US8802826 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
08/12/2014US8802823 Optimized Fc variants
08/12/2014US8802820 Fc variants with altered binding to FcRn
08/12/2014US8802818 Prostaglandin-F2 alpha receptor modulators and uses thereof
08/12/2014US8802815 Peptides and uses thereof to modulate IGF-1 synthesis and IGF-1 receptor expression
08/12/2014US8802667 Benzodiazepine derivatives
08/12/2014US8802631 Peptides and methods for the treatment of gliomas and other cancers
08/12/2014US8802397 Method of producing the polypeptide for treating virus-induced cancer
08/12/2014US8802383 Monoclonal antibodies and uses thereof
08/12/2014US8802382 Cobalamin assay
08/12/2014US8802381 Methods for predicting pregnancy outcome in a subject by HCG assay
08/12/2014US8802379 T1R3 binding assays
08/12/2014US8802129 Methods for treating retinopathy with extended therapeutic effect
08/12/2014US8802103 Compositions and methods for diagnosing and treating cancer
08/12/2014US8802102 Formulation of human antibodies for treating TNF-α associated disorders
08/12/2014US8802101 Formulation of human antibodies for treating TNF-α associated disorders
08/12/2014US8802100 Formulation of human antibodies for treating TNF-alpha associated disorders
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 1494